John J. Costanzi

Malignant Melanoma 1 - Cancer Treatment and Research John J. Costanzi 1983 edition

Marc Notes: Complemented by: Clinical management of malignant melanoma / edited by John J. Costanzi.; Includes bibliographical references and index. Table of Contents: 1. Epidemiologic and etiologic considerations in malignant melanoma.- 2. Clinical manifestations of primary cutaneous malignant melanoma.- 3. The diagnosis and management of primary melanoma of the head and neck.- 4. Malignant melanoma of mucosal sites.- 5. The pathology of human cutaneous melanoma.- 6. Characteristics of melanoma that predict the risk of metastases.- 7. The occurrence of melanoma and its relationship with host, lifestyle and environmental factors.- 8. Cell kinetics and human melanoma.- 9. The role of neuro-endocrine factors in human malignant melanoma.- 10. Adjuvant therapy following surgery for primary malignant melanoma.- 11. The role limb perfusion in the management of malignant melanoma.- 12. The chemotherapy of human malignant melanoma. Publisher Marketing: Where do you begin to look for a recent, authoritative article on the of a particular malignancy? The few general onco diagnosis or management logy textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often prelimi nary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by divid ing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more."